These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Bisphosphonates and bone diseases: past, present and future. Heymann D Curr Pharm Des; 2010; 16(27):2948-9. PubMed ID: 20722613 [No Abstract] [Full Text] [Related]
47. Polydatin for treating atherosclerotic diseases: A functional and mechanistic overview. Wu M; Li X; Wang S; Yang S; Zhao R; Xing Y; Liu L Biomed Pharmacother; 2020 Aug; 128():110308. PubMed ID: 32480216 [TBL] [Abstract][Full Text] [Related]
48. Bisphosphonates and atherosclerosis. Ylitalo R Gen Pharmacol; 2000 Dec; 35(6):287-96. PubMed ID: 11922958 [TBL] [Abstract][Full Text] [Related]
49. Disambiguating the bisphosphonates. Van den Wyngaert T; Huizing MT; Vermorken JB Ann Oncol; 2008 Jul; 19(7):1357-1359. PubMed ID: 18522931 [No Abstract] [Full Text] [Related]
50. Do bisphosphonates and statins have a role in spondyloarthritis management? Maksymowych WP Curr Rheumatol Rep; 2008 Oct; 10(5):364-70. PubMed ID: 18817639 [TBL] [Abstract][Full Text] [Related]
52. Comments on Addolorata Corrado et al. review "Extra skeletal effects of bisphosphonates". Singh B; Singh S; Nagraj C Joint Bone Spine; 2007 Oct; 74(5):518; author reply 518-9. PubMed ID: 17900960 [No Abstract] [Full Text] [Related]
53. The ODYSSEY Outcomes trial: Clinical implications and exploration of the limits of what can be achieved through lipid lowering. Maki KC J Clin Lipidol; 2018; 12(5):1102-1105. PubMed ID: 29941396 [No Abstract] [Full Text] [Related]
55. Foreword: bisphosphonates. Burr D; Russell G Bone; 2011 Jul; 49(1):1. PubMed ID: 21665184 [No Abstract] [Full Text] [Related]
56. Correlation research between osteoporosis and left ventricular hypertrophy in older men. Huang C; Li S Arch Med Sci; 2016 Dec; 12(6):1220-1224. PubMed ID: 27904511 [TBL] [Abstract][Full Text] [Related]
57. Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study. Coloma PM; de Ridder M; Bezemer I; Herings RM; Gini R; Pecchioli S; Scotti L; Rijnbeek P; Mosseveld M; van der Lei J; Trifirò G; Sturkenboom M; Osteoporos Int; 2016 May; 27(5):1857-67. PubMed ID: 26694594 [TBL] [Abstract][Full Text] [Related]
58. Osteoporosis Is Associated With High Risk for Coronary Heart Disease: A Population-Based Cohort Study. Chen SJ; Lin CS; Lin CL; Kao CH Medicine (Baltimore); 2015 Jul; 94(27):e1146. PubMed ID: 26166125 [TBL] [Abstract][Full Text] [Related]
59. Bisphosphonates and risk of cardiovascular events: a meta-analysis. Kim DH; Rogers JR; Fulchino LA; Kim CA; Solomon DH; Kim SC PLoS One; 2015; 10(4):e0122646. PubMed ID: 25884398 [TBL] [Abstract][Full Text] [Related]
60. Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study. Kang JH; Keller JJ; Lin HC Osteoporos Int; 2013 Jan; 24(1):271-7. PubMed ID: 23152093 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]